Nov 2018 $4 M No. 5 $2 to $10 million 33
Swift Biosciences, Inc.: Raise no. 5, Nov 2018 × Investors in this round 33 investors had bought by the notice of Nov 13, 2018: 33 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $7 M offered; $3 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Nathan Wood · Executive Officer, Director Dan Kidle · Director Dan Watkins · Director Jack Ball · Director Linda Tufts · Director Mark Lewis · Director Walter Young · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Nathan Wood, President. Source: SEC Form D, newest notice filed Nov 13, 2018. Read the notice at the SEC .
equity SEC May 2017 $12 M No. 4 $10 to $50 million 38
Swift Biosciences, Inc.: Raise no. 4, May 2017 × Investors in this round 38 investors had bought by the notice of Jun 12, 2017: 38 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $12 M of $12 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Eric Halverson · Executive Officer Timothy Harkins, PhD · Executive Officer, Director Dan Kidle · Director Dan Watkins · Director Jack Ball, Jr. · Director Mark Lewis · Director Peter Kleinhenz · Director Walter Young · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Eric Halverson, Treasurer. Source: SEC Form D, newest notice filed Jun 12, 2017. Read the notice at the SEC .
equity SEC Apr 2016 $3 M No. 3 $2 to $10 million 31
Swift Biosciences, Inc.: Raise no. 3, Apr 2016 × Investors in this round 31 investors had bought by the notice of Apr 27, 2016: 31 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $5 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Eric Halverson · Executive Officer Timothy Harkins, PhD · Executive Officer, Director Vladimir Makarov · Executive Officer, Director Dan Watkins · Director Jack Ball, Jr. · Director Peter Kleinhenz · Director Walter Young · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Eric Halverson, Treasurer. Source: SEC Form D, newest notice filed Apr 27, 2016. Read the notice at the SEC .
equity, options SEC Sep 2015 $2 M No. 2 Under $2 million 13
Swift Biosciences, Inc.: Raise no. 2, Sep 2015 × Investors in this round 13 investors had bought by the notice of Sep 10, 2015: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $3 M offered; $1 M still to sell
Smallest investment taken $7,000
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Tim Harkins · Executive Officer, Director Vladimir Makarov · Executive Officer, Director Dan Watkins · Director Jack Ball, Jr. · Director Peter Kleinhenz · Director Walter Young · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Eric Halverson, Authorized Signatory. Source: SEC Form D, newest notice filed Sep 10, 2015. Read the notice at the SEC .
equity, options SEC Oct 2013 $7 M No. 1 $2 to $10 million 11
Swift Biosciences, Inc.: Raise no. 1, Oct 2013 × Investors in this round 11 investors had bought by the notice of Oct 16, 2013: 11 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M of $7 M offered
Smallest investment taken $8,450
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Olson · Executive Officer, Director Vladimir Makarov · Executive Officer, Director Dan Watkins · Director Jack Ball, Jr. · Director Peter Kleinhenz · Director Walter Young · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David Olson, President & CEO. Source: SEC Form D, newest notice filed Oct 16, 2013. Read the notice at the SEC .
equity, options SEC